5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.84▲ | 5.80▲ | 5.76▲ | 5.87▲ | 6.13▼ |
MA10 | 5.82▲ | 5.74▲ | 5.74▲ | 6.10▼ | 6.70▼ |
MA20 | 5.78▲ | 5.73▲ | 5.73▲ | 6.06▼ | 7.14▼ |
MA50 | 5.72▲ | 5.79▲ | 5.96▼ | 6.84▼ | 4.79▲ |
MA100 | 5.72▲ | 5.99▼ | 6.05▼ | 7.09▼ | 5.89▼ |
MA200 | 5.76▲ | 6.03▼ | 6.37▼ | 5.43▲ | 7.69▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.010▲ | 0.026▲ | 0.032▲ | 0.010▲ | -0.350▼ |
RSI | 82.636▲ | 67.480▲ | 55.831▲ | 39.769▼ | 46.291▼ |
STOCH | 88.485▲ | 92.157▲ | 55.856 | 25.042 | 13.138▼ |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -76.577▼ | -92.442▼ |
CCI | 174.212▲ | 203.627▲ | 215.781▲ | -76.302 | -112.742▼ |
Thursday, January 14, 2021 04:00 PM
The dividend yield measures the ratio of dividends paid / share price. Companies with a higher dividend yield tend to have a business model that allows them to pay out more dividends from net income ...
|
Monday, January 11, 2021 01:26 AM
CymaBay Therapeutics (NASDAQ:CBAY) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a note issued to investors on Saturday, BidAskClub reports. CBAY ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
22/01/21 | 5.70 | 5.89 | 5.64 | 5.88 | 636,200 |
21/01/21 | 5.73 | 5.83 | 5.62 | 5.72 | 839,300 |
20/01/21 | 5.92 | 6.01 | 5.66 | 5.75 | 1,100,000 |
19/01/21 | 6.20 | 6.20 | 5.87 | 5.90 | 1,309,900 |
15/01/21 | 6.17 | 6.30 | 6.02 | 6.09 | 667,300 |
14/01/21 | 6.08 | 6.235 | 6.08 | 6.21 | 649,800 |
13/01/21 | 6.34 | 6.422 | 6.06 | 6.08 | 861,900 |
12/01/21 | 6.55 | 6.73 | 6.30 | 6.36 | 674,700 |
11/01/21 | 6.38 | 6.64 | 6.32 | 6.55 | 581,785 |
08/01/21 | 6.27 | 6.72 | 6.24 | 6.41 | 1,328,100 |
|
|
||||
|
|
||||
|
|